Skip to main content

Home
Browse by Topic
Issues
PSS Guide
- Index
- Introduction
Special Series
Multimedia
Subscribe

Home
Browse by Topic
Issues
PSS Guide
- Index
- Introduction
Special Series
Multimedia
Subscribe

Katie Kerrigan, DO

Assistant Professor of Internal Medicine
Division of Medical Oncology
Huntsman Cancer Institute at University of Utah
Salt Lake City, UT

Authored Items

Best Practices: Biomarkers and Treatment Selection in the Management of Advanced NSCLC

By Wallace Akerley, MD; Katie Kerrigan, DO

Best Practices: Biomarkers and Treatment Selection in the Management of Advanced NSCLC

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of patients with advanced non–small-cell lung cancer (NSCLC) by demonstrating significantly better outcomes and tolerability than conventional chemotherapy. Read More ›

Home
About
Contact Us
Subscribe

© Amplity Health. All Rights Reserved. Privacy Policy.

Subscribe Today!

To sign up for our free e-Newsletter or print publications, please enter your contact information below.

I'd like to receive:

OPM e-Newsletter

OPM print publication

I have reviewed and consent to the terms of OPM's Privacy Policy, and OPM has my permission to retain my information in its database, and to forward pertinent communications to me.